Methyltransferase-like 3 (METTL3) modifying mRNA via N6-methyladenosine is involved in gastric cancer, whereby it upregulates Cyclin D1 levels and activates the Akt signaling pathway, as shown in loss-of-function experiments in gastric cancer cells [102]. The gene discussed is METTL3; the disease is gastric cancer.